Edgestream Partners L.P. cut its stake in Colgate-Palmolive (NYSE:CL) by 70.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,498 shares of the company’s stock after selling 18,027 shares during the period. Edgestream Partners L.P.’s holdings in Colgate-Palmolive were worth $546,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of CL. Bancorpsouth Inc. boosted its holdings in Colgate-Palmolive by 4.6% during the first quarter. Bancorpsouth Inc. now owns 6,648 shares of the company’s stock worth $487,000 after buying an additional 295 shares in the last quarter. Sullivan Bruyette Speros & Blaney LLC boosted its holdings in Colgate-Palmolive by 12.8% during the first quarter. Sullivan Bruyette Speros & Blaney LLC now owns 5,785 shares of the company’s stock worth $423,000 after buying an additional 656 shares in the last quarter. Matrix Asset Advisors Inc. NY bought a new stake in Colgate-Palmolive during the first quarter worth approximately $203,000. Fort Washington Investment Advisors Inc. OH boosted its holdings in Colgate-Palmolive by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 18,458 shares of the company’s stock worth $1,351,000 after buying an additional 55 shares in the last quarter. Finally, Hayek Kallen Investment Management boosted its holdings in Colgate-Palmolive by 0.8% during the first quarter. Hayek Kallen Investment Management now owns 13,584 shares of the company’s stock worth $994,000 after buying an additional 103 shares in the last quarter. Institutional investors and hedge funds own 72.84% of the company’s stock.
A number of analysts recently weighed in on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Monday, October 23rd. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Deutsche Bank started coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective for the company. Finally, Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the company. Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $76.33.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the firm earned $0.73 EPS. The company’s revenue was up 2.8% compared to the same quarter last year. equities analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current year.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now owns 38,691 shares in the company, valued at approximately $2,831,407.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Victoria L. Dolan sold 9,000 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 181,048 shares of company stock valued at $13,168,995. Insiders own 1.02% of the company’s stock.
WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/24/colgate-palmolive-cl-stake-lessened-by-edgestream-partners-l-p.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.